U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 20

1.

The effects of timing of fine needle aspiration biopsies on gene expression profiles in breast cancers

(Submitter supplied) Paired fine needle aspiration biopsies (FNABs) of breast cancers were taken before (PRE) and after (POST) surgeries from 16 patients and compared the cDNA microarray data to determine the genes that were differentially expressed between the FNABs taken at the two time points. The timing of fine needle aspiration biopsies can be a confounding factor in microarray data analyses in breast cancer. FOS-related genes, which have been implicated in early hypoxia as well as the development of breast cancers, were differentially expressed before and after surgery. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL7025
32 Samples
Download data: GPR
Series
Accession:
GSE12072
ID:
200012072
2.

Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platforms:
GPL8432 GPL6883
50 Samples
Download data
Series
Accession:
GSE23386
ID:
200023386
3.

Gene profiling using archival formalin-fixed paraffin-embedded breast cancer specimens can generate informative microarray data: A comparison with matched fresh fine needle aspiration biopsy samples (FNA samples)

(Submitter supplied) The Formalin-Fixed Paraffin-Embedded (FFPE) samples on selected breast cancer subtypes (ER+/Her2-, ER+/Her2+, ER-/Her2+, and ER-/Her2-) and their paired fresh fine needle aspirated biopsies (FNA) were investigated. The cases represented different subtypes of breast cancers based on their clinical receptors ER (E) and Her2 (H) status to demonstrate the ability of gene profiles to differentiate these tumors. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6883
25 Samples
Download data: TXT
Series
Accession:
GSE23385
ID:
200023385
4.

Gene profiling using archival formalin-fixed paraffin-embedded breast cancer specimens can generate informative microarray data: A comparison with matched fresh fine needle aspiration biopsy samples (FFPE samples)

(Submitter supplied) The Formalin-Fixed Paraffin-Embedded (FFPE) samples on selected breast cancer subtypes (ER+/Her2-, ER+/Her2+, ER-/Her2+, and ER-/Her2-) and their paired fresh fine needle aspirated biopsies (FNA) were investigated. The cases represented different subtypes of breast cancers based on their clinical receptors ER (E) and Her2 (H) status to demonstrate the ability of gene profiles to differentiate these tumors. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL8432
25 Samples
Download data: TXT
Series
Accession:
GSE23384
ID:
200023384
5.

Breast tumor miRNA profiling

(Submitter supplied) Comparison of miRNA expression profiles in breast tumors clinically annotated for ErbB2, ER, and PR expression, as well as additional parameters. Keywords: Expression profiling of breast tumor biopsies
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by array
Platform:
GPL3238
20 Samples
Download data
Series
Accession:
GSE4589
ID:
200004589
6.

Normal vs. Tumor Prostate miRNA

(Submitter supplied) Comparison of miRNA expression profiles in a small set of prostate needle core biopsies or fine needle aspirates. Keywords: Expression profiling of prostate needle core biopsies
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by array
Platform:
GPL3238
6 Samples
Download data: GPR
Series
Accession:
GSE4574
ID:
200004574
7.

PC3 vs LNCaP amplified and unamplified miRNA

(Submitter supplied) Comparison of miRNA expression profiles directly comparing PC3 cells to LNCaP cells using unamplified and amplified miRNA. Keywords: Expression profiling of hormone sensitive vs. insensitive prostate cancer cell lines and evaluation of amplification fidelity
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by array
Platform:
GPL3238
9 Samples
Download data
Series
Accession:
GSE4572
ID:
200004572
8.

Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer

(Submitter supplied) Tamoxifen is the most widely prescribed anti-estrogen treatment for patients with ER-positive breast cancer. However, there is still a need for biomarkers that reliably predict endocrine sensitivity in breast cancers and these may well be expressed in a dynamic manner. In this study we assessed gene expression changes at multiple time points (days 1, 2, 4, 7, 14) after tamoxifen treatment in the ER-positive ZR-75-1 xenograft model that displays significant changes in apoptosis, proliferation and angiogenesis within 2 days of therapy. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL506
32 Samples
Download data: TXT
Series
Accession:
GSE22386
ID:
200022386
9.

Intratumor Heterogeneity and Precision of Microarray-Based Predictors of Breast Cancer Biology and Clinical Outcome

(Submitter supplied) Genome-wide expression profiling was performed on 50 core needle biopsies from 18 breast cancer patients using Affymetrix GeneChip Human Genome Plus 2.0 Arrays.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
50 Samples
Download data: CEL
Series
Accession:
GSE23593
ID:
200023593
10.

Gene expression profiling of sequential metastatic biopsies for biomarker discovery in breast cancer

(Submitter supplied) The feasibility of longitudinal metastatic biopsies for gene expression profiling in breast cancer is unexplored. Dynamic changes in gene expression can potentially predict efficacy of targeted cancer drugs. Patients enrolled in a phase III trial of metastatic breast cancer with sunitinib combined with docetaxel (SU+DOC) versus docetaxel alone (DOC) were offered to participate in a translational substudy comprising longitudinal fine needle aspiration biopsies (FNAB) and positron emission imaging before (T1) and two weeks after start of treatment (T2). more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
29 Samples
Download data: CEL
Series
Accession:
GSE54323
ID:
200054323
11.

A new gene expression signature, the ClinicoMolecular Triad Classification, may improve prediction and prognostication of breast cancer at the time of diagnosis

(Submitter supplied) When making treatment decisions, oncologists often stratify breast cancers into a low-risk group (ER+, low grade); an intermediate-risk group (ER+, high grade); and a high-risk group that includes Her2+ and triple-negative (ER-/PR-/Her2-) tumors. None of the currently available gene signatures correlates to this clinical classification. We aimed to develop a test that is practical for the oncologists, that offers both molecular characterization of BCs, and improved prediction of prognosis and treatment response. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6104
161 Samples
Download data: TXT
Series
Accession:
GSE16987
ID:
200016987
12.

Comparability and concordance of replicated microarray data.

(Submitter supplied) To measures the comparability and concordance of Illumina microarray, a series of 30 samples of Universal Human Reference RNA (UHRR) were set as controls for every single chip of total 30 Human-Ref V2 BeadChips. The average bead number of the 30 arrays was 42.3±8.1 for any bead type over the 22,184 probes. A high average correlation coefficient (r) value was obtained as 0.9908±0077 relative to each other of the expression intensity values from the 30 duplicate UHRR samples.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6104
30 Samples
Download data: TXT
Series
Accession:
GSE16984
ID:
200016984
13.

Expression profiling of circulating miRNAs in Luminal A breast cancer

(Submitter supplied) Breast cancer is a common disease with distinct tumor subtypes which can be phenotypically characterized by estrogen receptor, progesterone receptor and HER2/neu receptor status. MiRNAs play regulatory roles in tumor initiation and progression. Altered miRNA expression has been demonstrated in a variety of cancer states to date presenting the potential for exploitation as cancer specific biomarkers. more...
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by array
Platforms:
GPL17040 GPL17039
28 Samples
Download data: TXT
Series
Accession:
GSE46355
ID:
200046355
14.

Gene expression abnormalities in histologically normal breast epithelium of breast cancer patients

(Submitter supplied) Normal-appearing epithelium of cancer patients can harbor occult genetic abnormalities. Data comprehensively comparing gene expression between histologically normal breast epithelium of breast cancer patients and cancer-free controls are limited. The present study compares global gene expression between these groups. We performed microarrays using RNA from microdissected histologically normal terminal ductal-lobular units (TDLU) from 2 groups: (i) cancer normal (CN) (TDLUs adjacent to untreated ER1 breast cancers (n = 14)) and (ii) reduction mammoplasty (RM) (TDLUs of age-matched women without breast disease (n = 15)). more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS3139
Platform:
GPL96
29 Samples
Download data: CEL
Series
Accession:
GSE9574
ID:
200009574
15.
Full record GDS3139

Breast cancer: histologically normal breast epithelium

Analysis of histologically normal breast epithelia of breast cancer patients. Results provide insight into the molecular abnormalities in normal appearing breast epithelium in breast cancer and the roles these abnormalities play in carcinogenesis.
Organism:
Homo sapiens
Type:
Expression profiling by array, count, 2 disease state sets
Platform:
GPL96
Series:
GSE9574
29 Samples
Download data: CEL
DataSet
Accession:
GDS3139
ID:
3139
16.

Biological Classification of Breast Cancer by Real-Time Quantitative RTPCR: Comparisons to Microarray and Histopathology

(Submitter supplied) Microarrays have shown that gene expression patterns can be used to molecularly classify breast cancers into distinct and clinically significant groups. In order to translate these profiles into routine diagnostics, we have recapitulated a microarray breast cancer classification using real-time quantitative (q)RT-PCR. We performed statistical analyses on multiple independent microarray datasets to select an “intrinsic” gene set that can classify breast tumors into four different subtypes designated as Luminal, Normal-like, HER2+/ER-, and Basal-like. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platforms:
GPL885 GPL887 GPL1390
126 Samples
Download data
Series
Accession:
GSE2607
ID:
200002607
17.

Gene expression profiling of the 20 human early breast carcinomas by three miaroarray platforms

(Submitter supplied) In this study, we profiled gene expressions on 20 biopsy tissues of early stage breast carcinoma using Applied Biosystem’s Human Genome Survey Microarrays. Two main previously defined clinically relevant subtypes of breast tumors, Luminal A (longest survival time) and Basal (shortest survival time) were identified. Statistical analysis identified 1210 genes as signature genes characterizing the two subtypes of breast cancer. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platforms:
GPL1843 GPL1426 GPL1708
80 Samples
Download data
Series
Accession:
GSE3155
ID:
200003155
18.

Gene Expression Profiling of matched Ductal Carcinomas in Situ and Invasive Breast Tumors

(Submitter supplied) This is a matched-pair analysis of ductal carcinoma in situ (DCIS) and invasive component (IDC) of nine breast ductal carcinoma to identify novel molecular markers characterizing the transition from DCIS to IDC for a better understanding of its molecular biology. Keywords: Affymetrix-based Microarrays in Mamma carcinoma
Organism:
Homo sapiens
Type:
Expression profiling by array
Datasets:
GDS2045 GDS2046
Platforms:
GPL570 GPL96
24 Samples
Download data
Series
Accession:
GSE3893
ID:
200003893
19.
Full record GDS2046

Ductal carcinoma in situ to invasive ductal carcinoma progression (HG-U133 2.0)

Analysis of preinvasive ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC) tumors. Pairs of patient-matched DCIS and IDC tumor specimens analyzed. Results provide insight into the mechanisms underlying the progression of DCIS to IDC.
Organism:
Homo sapiens
Type:
Expression profiling by array, transformed count, 2 disease state, 7 individual sets
Platform:
GPL570
Series:
GSE3893
14 Samples
Download data
DataSet
Accession:
GDS2046
ID:
2046
20.
Full record GDS2045

Ductal carcinoma in situ to invasive ductal carcinoma progression (HG-U133A)

Analysis of preinvasive ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC) tumors. Pairs of patient-matched DCIS and IDC tumor specimens analyzed. Results provide insight into the mechanisms underlying the progression of DCIS to IDC.
Organism:
Homo sapiens
Type:
Expression profiling by array, transformed count, 2 disease state, 5 individual sets
Platform:
GPL96
Series:
GSE3893
10 Samples
Download data
DataSet
Accession:
GDS2045
ID:
2045
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=2|qty=2|blobid=MCID_66daf353b8e5607ab86f2d5a|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Support Center